Literature DB >> 23551332

Hypogammaglobulinemia in the early period after liver transplantation in children.

Yael Mozer-Glassberg1, Raanan Shamir, Ran Steinberg, Gili Kadmon, Efrat Har-Lev, Eytan Mor, Rivka Shapiro, Tommy Schonfeld, Elhanan Nahum.   

Abstract

Data, on the kinetic and serum levels of immunoglobulins in the immediate post-liver transplantation (LTx) period, are sparse with existing studies limited to adults or case reports of children. The aim of this study is to describe the phenomenon of hypogammaglobulinemia (HGG) in the immediate post-transplantation period among children undergoing LTx. A retrospective 10-yr chart review was conducted of all children who underwent LTx at a fourth-level pediatric medical center. Fifty-seven, of the 76 children who underwent LTx, were included in the study. Seventeen (29.8%) (mean age, 6.8 ± 5.2 yr) had HGG (11-IgG, 1-IgG+IgA, 1-IgG+IgM, 4-IgG+IgA+IgM), detected at 2 to 25 d after transplantation. Abdominal fluid was drained for 5 to 42 d; the amount drained until detection of HGG measured 27-668 mL/kg. HGG was associated with increased infection rate 0.9 episodes/patient vs. 0.17 episodes/patient (p < 0.01) in children without detected HGG. In conclusion, HGG is not rare in the immediate post-LTx period in children, and it may place patients at increased risk of infection. Further studies are needed to delineate the rate of occurrence, risk factors, and clinical implications of hypogammaglobulinemia in this patient population.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2013        PMID: 23551332     DOI: 10.1111/ctr.12116

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  2 in total

1.  Liver transplantation reverses hypergammaglobulinemia in patients with chronic hepatic failure.

Authors:  Diana Lebherz-Eichinger; Remy Schwarzer; Michael C Motal; Daniel A Klaus; Andreas Mangold; Hendrik J Ankersmit; Gabriela A Berlakovich; Claus G Krenn; Georg A Roth
Journal:  Biochem Med (Zagreb)       Date:  2015-06-05       Impact factor: 2.313

2.  The Contribution of Serum Complement Component 3 Levels to 90-Day Mortality in Living Donor Liver Transplantation.

Authors:  Saeko Fukui; Masaaki Hidaka; Shoichi Fukui; Shimpei Morimoto; Takanobu Hara; Akihiko Soyama; Tomohiko Adachi; Hajime Matsushima; Takayuki Tanaka; Mai Fuchigami; Hiroo Hasegawa; Katsunori Yanagihara; Susumu Eguchi
Journal:  Front Immunol       Date:  2021-07-19       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.